ADMA Biologics, Inc(NASDAQ:ADMA) 
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of pr...
Website: http://www.admabiologics.com
Founded: 2007
Full Time Employees: 313
CEO: Adam Grossman
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 18.44
H 19.00
L 17.65
C 18.01
V 3,762,481
10EMA 18.01
20EMA 18.01
60EMA 18.01
120EMA 18.01
250EMA 18.01